1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Immunosuppressants 1.2.3 Anti-Inflammatory Drugs 1.2.4 Corticosteroids 1.2.5 Nonsteroidal Anti-inflammatory Drugs 1.2.6 Biologics 1.2.7 Others 1.3 Market by Application 1.3.1 Global Autoimmune Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Independent Pharmacies 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Autoimmune Disease Therapeutics Market Perspective (2016-2027) 2.2 Autoimmune Disease Therapeutics Growth Trends by Regions 2.2.1 Autoimmune Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Autoimmune Disease Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Autoimmune Disease Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Autoimmune Disease Therapeutics Industry Dynamic 2.3.1 Autoimmune Disease Therapeutics Market Trends 2.3.2 Autoimmune Disease Therapeutics Market Drivers 2.3.3 Autoimmune Disease Therapeutics Market Challenges 2.3.4 Autoimmune Disease Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Autoimmune Disease Therapeutics Players by Revenue 3.1.1 Global Top Autoimmune Disease Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Autoimmune Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Autoimmune Disease Therapeutics Revenue 3.4 Global Autoimmune Disease Therapeutics Market Concentration Ratio 3.4.1 Global Autoimmune Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Therapeutics Revenue in 2020 3.5 Autoimmune Disease Therapeutics Key Players Head office and Area Served 3.6 Key Players Autoimmune Disease Therapeutics Product Solution and Service 3.7 Date of Enter into Autoimmune Disease Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Autoimmune Disease Therapeutics Breakdown Data by Type 4.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2022-2027) 5 Autoimmune Disease Therapeutics Breakdown Data by Application 5.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Autoimmune Disease Therapeutics Market Size (2016-2027) 6.2 North America Autoimmune Disease Therapeutics Market Size by Type 6.2.1 North America Autoimmune Disease Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Autoimmune Disease Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Autoimmune Disease Therapeutics Market Size by Type (2016-2027) 6.3 North America Autoimmune Disease Therapeutics Market Size by Application 6.3.1 North America Autoimmune Disease Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Autoimmune Disease Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Autoimmune Disease Therapeutics Market Size by Application (2016-2027) 6.4 North America Autoimmune Disease Therapeutics Market Size by Country 6.4.1 North America Autoimmune Disease Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Autoimmune Disease Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Autoimmune Disease Therapeutics Market Size (2016-2027) 7.2 Europe Autoimmune Disease Therapeutics Market Size by Type 7.2.1 Europe Autoimmune Disease Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Autoimmune Disease Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Autoimmune Disease Therapeutics Market Size by Type (2016-2027) 7.3 Europe Autoimmune Disease Therapeutics Market Size by Application 7.3.1 Europe Autoimmune Disease Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Autoimmune Disease Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Autoimmune Disease Therapeutics Market Size by Application (2016-2027) 7.4 Europe Autoimmune Disease Therapeutics Market Size by Country 7.4.1 Europe Autoimmune Disease Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Autoimmune Disease Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type 8.2.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application 8.3.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region 8.4.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Autoimmune Disease Therapeutics Market Size (2016-2027) 9.2 Latin America Autoimmune Disease Therapeutics Market Size by Type 9.2.1 Latin America Autoimmune Disease Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Autoimmune Disease Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Autoimmune Disease Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Autoimmune Disease Therapeutics Market Size by Application 9.3.1 Latin America Autoimmune Disease Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Autoimmune Disease Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Autoimmune Disease Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Autoimmune Disease Therapeutics Market Size by Country 9.4.1 Latin America Autoimmune Disease Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Autoimmune Disease Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type 10.2.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application 10.3.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country 10.4.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Autoimmune Disease Therapeutics Introduction 11.1.4 Pfizer Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Autoimmune Disease Therapeutics Introduction 11.2.4 Novartis Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Johnson & Johnson Services 11.3.1 Johnson & Johnson Services Company Details 11.3.2 Johnson & Johnson Services Business Overview 11.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Introduction 11.3.4 Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.3.5 Johnson & Johnson Services Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Autoimmune Disease Therapeutics Introduction 11.4.4 Merck Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.4.5 Merck Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Autoimmune Disease Therapeutics Introduction 11.5.4 Sanofi Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 Abott 11.6.1 Abott Company Details 11.6.2 Abott Business Overview 11.6.3 Abott Autoimmune Disease Therapeutics Introduction 11.6.4 Abott Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.6.5 Abott Recent Development 11.7 Bristol-Myers Squibb 11.7.1 Bristol-Myers Squibb Company Details 11.7.2 Bristol-Myers Squibb Business Overview 11.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Introduction 11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.7.5 Bristol-Myers Squibb Recent Development 11.8 Amgen 11.8.1 Amgen Company Details 11.8.2 Amgen Business Overview 11.8.3 Amgen Autoimmune Disease Therapeutics Introduction 11.8.4 Amgen Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.8.5 Amgen Recent Development 11.9 Bayer 11.9.1 Bayer Company Details 11.9.2 Bayer Business Overview 11.9.3 Bayer Autoimmune Disease Therapeutics Introduction 11.9.4 Bayer Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.9.5 Bayer Recent Development 11.10 F. Hoffmann-La Roche 11.10.1 F. Hoffmann-La Roche Company Details 11.10.2 F. Hoffmann-La Roche Business Overview 11.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Introduction 11.10.4 F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.10.5 F. Hoffmann-La Roche Recent Development 11.11 Eli Lilly and Company 11.11.1 Eli Lilly and Company Company Details 11.11.2 Eli Lilly and Company Business Overview 11.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Introduction 11.11.4 Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2016-2021) 11.11.5 Eli Lilly and Company Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Immunosuppressants Table 3. Key Players of Anti-Inflammatory Drugs Table 4. Key Players of Corticosteroids Table 5. Key Players of Nonsteroidal Anti-inflammatory Drugs Table 6. Key Players of Biologics Table 7. Key Players of Others Table 8. Global Autoimmune Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Autoimmune Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Autoimmune Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Autoimmune Disease Therapeutics Market Share by Regions (2016-2021) Table 12. Global Autoimmune Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Autoimmune Disease Therapeutics Market Share by Regions (2022-2027) Table 14. Autoimmune Disease Therapeutics Market Trends Table 15. Autoimmune Disease Therapeutics Market Drivers Table 16. Autoimmune Disease Therapeutics Market Challenges Table 17. Autoimmune Disease Therapeutics Market Restraints Table 18. Global Autoimmune Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Autoimmune Disease Therapeutics Market Share by Players (2016-2021) Table 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Therapeutics as of 2020) Table 21. Ranking of Global Top Autoimmune Disease Therapeutics Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Autoimmune Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Autoimmune Disease Therapeutics Product Solution and Service Table 25. Date of Enter into Autoimmune Disease Therapeutics Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 28. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2016-2021) Table 29. Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Autoimmune Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2016-2021) Table 33. Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 36. North America Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 38. North America Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 65. Pfizer Company Details Table 66. Pfizer Business Overview Table 67. Pfizer Autoimmune Disease Therapeutics Product Table 68. Pfizer Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 69. Pfizer Recent Development Table 70. Novartis Company Details Table 71. Novartis Business Overview Table 72. Novartis Autoimmune Disease Therapeutics Product Table 73. Novartis Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 74. Novartis Recent Development Table 75. Johnson & Johnson Services Company Details Table 76. Johnson & Johnson Services Business Overview Table 77. Johnson & Johnson Services Autoimmune Disease Therapeutics Product Table 78. Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 79. Johnson & Johnson Services Recent Development Table 80. Merck Company Details Table 81. Merck Business Overview Table 82. Merck Autoimmune Disease Therapeutics Product Table 83. Merck Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 84. Merck Recent Development Table 85. Sanofi Company Details Table 86. Sanofi Business Overview Table 87. Sanofi Autoimmune Disease Therapeutics Product Table 88. Sanofi Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 89. Sanofi Recent Development Table 90. Abott Company Details Table 91. Abott Business Overview Table 92. Abott Autoimmune Disease Therapeutics Product Table 93. Abott Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 94. Abott Recent Development Table 95. Bristol-Myers Squibb Company Details Table 96. Bristol-Myers Squibb Business Overview Table 97. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product Table 98. Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 99. Bristol-Myers Squibb Recent Development Table 100. Amgen Company Details Table 101. Amgen Business Overview Table 102. Amgen Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 103. Amgen Recent Development Table 104. Bayer Company Details Table 105. Bayer Business Overview Table 106. Bayer Autoimmune Disease Therapeutics Product Table 107. Bayer Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 108. Bayer Recent Development Table 109. F. Hoffmann-La Roche Company Details Table 110. F. Hoffmann-La Roche Business Overview Table 111. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product Table 112. F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 113. F. Hoffmann-La Roche Recent Development Table 114. Eli Lilly and Company Company Details Table 115. Eli Lilly and Company Business Overview Table 116. Eli Lilly and Company Autoimmune Disease Therapeutics Product Table 117. Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million) Table 118. Eli Lilly and Company Recent Development Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Global Autoimmune Disease Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Immunosuppressants Features Figure 3. Anti-Inflammatory Drugs Features Figure 4. Corticosteroids Features Figure 5. Nonsteroidal Anti-inflammatory Drugs Features Figure 6. Biologics Features Figure 7. Others Features Figure 8. Global Autoimmune Disease Therapeutics Market Share by Application: 2020 VS 2027 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Independent Pharmacies Case Studies Figure 12. Others Case Studies Figure 13. Autoimmune Disease Therapeutics Report Years Considered Figure 14. Global Autoimmune Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Autoimmune Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Autoimmune Disease Therapeutics Market Share by Regions: 2020 VS 2027 Figure 17. Global Autoimmune Disease Therapeutics Market Share by Regions (2022-2027) Figure 18. Global Autoimmune Disease Therapeutics Market Share by Players in 2020 Figure 19. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Therapeutics as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2020 Figure 21. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2016-2021) Figure 22. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2022-2027) Figure 23. North America Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Autoimmune Disease Therapeutics Market Share by Type (2016-2027) Figure 25. North America Autoimmune Disease Therapeutics Market Share by Application (2016-2027) Figure 26. North America Autoimmune Disease Therapeutics Market Share by Country (2016-2027) Figure 27. United States Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Autoimmune Disease Therapeutics Market Share by Type (2016-2027) Figure 31. Europe Autoimmune Disease Therapeutics Market Share by Application (2016-2027) Figure 32. Europe Autoimmune Disease Therapeutics Market Share by Country (2016-2027) Figure 33. Germany Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Type (2016-2027) Figure 41. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Application (2016-2027) Figure 42. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Region (2016-2027) Figure 43. China Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Autoimmune Disease Therapeutics Market Share by Type (2016-2027) Figure 51. Latin America Autoimmune Disease Therapeutics Market Share by Application (2016-2027) Figure 52. Latin America Autoimmune Disease Therapeutics Market Share by Country (2016-2027) Figure 53. Mexico Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Type (2016-2027) Figure 57. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Application (2016-2027) Figure 58. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Country (2016-2027) Figure 59. Turkey Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Pfizer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 64. Johnson & Johnson Services Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 65. Merck Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 66. Sanofi Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 67. Abott Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 69. Amgen Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 70. Bayer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 72. Eli Lilly and Company Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Pfizer Novartis Johnson & Johnson Services Merck Sanofi Abott Bristol-Myers Squibb Amgen Bayer F. Hoffmann-La Roche Eli Lilly and Company